Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging
- PMID: 16609809
- DOI: 10.1007/s00415-006-0162-7
Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging
Abstract
Riluzole prolongs survival in amyotrophic lateral sclerosis. The temporal and spatial profile of its effect on the brain is unknown. We used proton magnetic resonance spectroscopic imaging to evaluate the neuronal response to 1 day of riluzole treatment in motor and non-motor regions of the brain. In 10 patients the N-acetylaspartate/total creatine (NAA/Cr) ratio increased in the precentral gyrus and supplementary motor area, but not in the post-central gyrus or parietal lobe. Improvement in cortical neuronal metabolic function in the motor cortex occurs early with riluzole treatment.
Similar articles
-
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.JAMA Neurol. 2013 Aug;70(8):1009-16. doi: 10.1001/jamaneurol.2013.234. JAMA Neurol. 2013. PMID: 23797905 Free PMC article.
-
Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.Brain. 2013 May;136(Pt 5):1361-70. doi: 10.1093/brain/awt085. Brain. 2013. PMID: 23616585
-
Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy.AJNR Am J Neuroradiol. 2003 Mar;24(3):476-80. AJNR Am J Neuroradiol. 2003. PMID: 12637300 Free PMC article.
-
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 13129806 Review.
-
Biological markers in the diagnosis and treatment of ALS.J Neurol Sci. 1999 Jun;165 Suppl 1:S27-32. doi: 10.1016/s0022-510x(99)00023-4. J Neurol Sci. 1999. PMID: 10448978 Review.
Cited by
-
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.Eur J Neurol. 2010 Apr;17(4):526-e20. doi: 10.1111/j.1468-1331.2010.02951.x. Epub 2010 Feb 2. Eur J Neurol. 2010. PMID: 20136647 Free PMC article.
-
Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.PLoS One. 2012;7(4):e35607. doi: 10.1371/journal.pone.0035607. Epub 2012 Apr 23. PLoS One. 2012. PMID: 22539984 Free PMC article.
-
Lessons of ALS imaging: Pitfalls and future directions - A critical review.Neuroimage Clin. 2014 Feb 27;4:436-43. doi: 10.1016/j.nicl.2014.02.011. eCollection 2014. Neuroimage Clin. 2014. PMID: 24624329 Free PMC article. Review.
-
Sensory Dysfunction in ALS and Other Motor Neuron Diseases: Clinical Relevance, Histopathology, Neurophysiology, and Insights from Neuroimaging.Biomedicines. 2025 Feb 22;13(3):559. doi: 10.3390/biomedicines13030559. Biomedicines. 2025. PMID: 40149536 Free PMC article. Review.
-
The application of biomarkers in clinical trials for motor neuron disease.Biomark Med. 2010 Apr;4(2):281-97. doi: 10.2217/bmm.09.71. Biomark Med. 2010. PMID: 20406070 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical